Candel Therapeutics, Inc. (CADL)
10.18
+0.02
(+0.20%)
USD |
NASDAQ |
Oct 02, 16:00
10.20
+0.02
(+0.15%)
Pre-Market: 20:00
Candel Therapeutics EPS Diluted (Quarterly) : -0.5248 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.5248 |
| March 31, 2026 | -0.1421 |
| December 31, 2025 | -0.5373 |
| September 30, 2025 | -0.2053 |
| June 30, 2025 | -0.0931 |
| March 31, 2025 | 0.1347 |
| December 31, 2024 | -0.3957 |
| September 30, 2024 | -0.3326 |
| June 30, 2024 | -0.7442 |
| March 31, 2024 | -0.2816 |
| December 31, 2023 | -0.3828 |
| September 30, 2023 | -0.2917 |
| June 30, 2023 | -0.3324 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.3041 |
| December 31, 2022 | -0.1759 |
| September 30, 2022 | -0.3007 |
| June 30, 2022 | -0.144 |
| March 31, 2022 | -0.0305 |
| December 31, 2021 | 0.0461 |
| September 30, 2021 | -0.5633 |
| June 30, 2021 | -0.5953 |
| March 31, 2021 | -0.1536 |
| December 31, 2020 | -0.3595 |
| September 30, 2020 | -0.0876 |
| June 30, 2020 | -0.1002 |
| March 31, 2020 | -0.0608 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arcturus Therapeutics Holdings, Inc. | -0.8368 |
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -38.90M |
| Total Expenses (Quarterly) | 38.90M |
| Enterprise Value | 622.84M |
| Earnings Yield | -13.85% |
| Normalized Earnings Yield | -12.00 |